Deep Needling Protrusion of Lumbar Intervertebral Disc the Five Acupoints
A Prospective Cohort Study of Electroacupuncture Deep Needling Protrusion of Lumbar Intervertebral Disc the Five Acupoints in the Treatment of Lumbar Disc Herniation
1 other identifier
observational
175
0 countries
N/A
Brief Summary
Compare the curative effects of electroacupuncture deep needling difference in efficacy of the conservative treatment for lumbar five point therapy and routine western medicine, to explore the efficacy and superiority, open a new way for the treatment of lumbar disc herniation.Through a comparative analysis of the data on the efficacy of different TCM Syndrome Types in the subgroup of patients with, to explore the effect of Electroacupuncture of deep needling and five lumbar acupoint therapy is most suitable for the TCM syndrome type.Through follow-up, patients in the two groups moment condition and the survival of the state was evaluated, explore the effect of electroacupuncture deep needling the long-term effects of five lumbar acupoint therapy for treatment of lumbar disc herniation and factors that may influence the recurrence of symptoms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2016
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2016
CompletedFirst Submitted
Initial submission to the registry
June 5, 2016
CompletedFirst Posted
Study publicly available on registry
July 7, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2019
CompletedJuly 7, 2016
July 1, 2016
3.3 years
June 5, 2016
July 6, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
JOA
through study completion, an average of 13 months；before treatment，after the sixth treatment，after 3 months of treatment ，after 6 months of treatment ，after 1 year of treatment
VAS
through study completion, an average of 13 months；before treatment，after the sixth treatment，after 3 months of treatment ，after 6 months of treatment ，after 1 year of treatment
SF-36 quality of life questionnaire
Follow-up after treatment，period of about a year
Oswestry functional disorder questionnaire
Follow-up after treatment，period of about a year
Secondary Outcomes (2)
Patient satisfaction rating scale
Follow-up after treatment，period of about a year
Influencing factors questionnaire
Follow-up after treatment，period of about a year
Study Arms (2)
Exposed group
Long term curative effect of electroacupuncture treatment of lumbar intervertebral disc herniation in exposure group
control group
Long term efficacy of conventional treatment of lumbar disc herniation in the control group
Interventions
Electro acupuncture deep needling protrusion of lumbar intervertebral disc the five acupoints
Routine non operative treatment of Western Medicine
Eligibility Criteria
Patients with lumbar disc herniation from department of acupuncture and moxibustion in Third affiliated hospital of Beijing university of Chinese medicine
You may qualify if:
- Meet the criteria for the diagnosis
- The people whose age are between 18 to 75 years old.
- Course of no more than 20 years.
- TCM syndrome type belong to blood stasis, cold dampness syndrome, hot and humid, liver and kidney deficiency license.
- Pathological classification belongs to unilateral disc herniation or bilateral slipped disc.
- Signed informed consent will be.
You may not qualify if:
- Patients with severe lumbar disc herniation with surgical indications.
- Complicated by severe developmental spinal stenosis or other severe malformations.
- Weak constitution, or pregnant women, etc.
- Suffers from severe heart disease, high blood pressure, liver and kidney disease patients.
- Skin damage, ulceration or skin disease.
- Has a bleeding tendency in patients with hematologic diseases.
- Psychiatric patients.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Officials
- PRINCIPAL INVESTIGATOR
Guo Sheng Jun, undergraduate
The Third Affiliated Hospital of Beijing University of Chinese Medicine
- PRINCIPAL INVESTIGATOR
Wang Yi Li, undergraduate
The Third Affiliated Hospital of Beijing University of Chinese Medicine
- PRINCIPAL INVESTIGATOR
Li Dan, doctor
The Third Affiliated Hospital of Beijing University of Chinese Medicine
- PRINCIPAL INVESTIGATOR
Zhou Pei Juan, master
The Third Affiliated Hospital of Beijing University of Chinese Medicine
- PRINCIPAL INVESTIGATOR
Song Jia Shan, doctor
The Third Affiliated Hospital of Beijing University of Chinese Medicine
- PRINCIPAL INVESTIGATOR
Liu Ya Ru, master
The Third Affiliated Hospital of Beijing University of Chinese Medicine
- PRINCIPAL INVESTIGATOR
Song Yu Hui, undergraduate
The Third Affiliated Hospital of Beijing University of Chinese Medicine
- PRINCIPAL INVESTIGATOR
Li Zhao Qiang, undergraduate
The Third Affiliated Hospital of Beijing University of Chinese Medicine
- PRINCIPAL INVESTIGATOR
Zhang Hai Xia, undergraduate
The Third Affiliated Hospital of Beijing University of Chinese Medicine
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief physician
Study Record Dates
First Submitted
June 5, 2016
First Posted
July 7, 2016
Study Start
June 1, 2016
Primary Completion
September 1, 2019
Study Completion
September 1, 2019
Last Updated
July 7, 2016
Record last verified: 2016-07